Roivant Sciences Ltd.
$21.35B- Market cap
- $25.23B
- Debt
- +$412.94M
- Cash
- −$4.29B
Capital structure 98% equity / 2% debt · EV / Revenue 2584.97x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ROIV · current priceP/S 3054.57x
$34.93Latest market snapshot
Implied fair value · at RBLX's multiple
$0.0799.8% below market
0.01 ROIV revenue / share×6.33x RBLX P/S=$0.07
Market $34.93Implied $0.07
RBLX · current priceP/S 6.33x
$43.31Latest market snapshot
Implied fair value · at ROIV's multiple
$21,662.2249,916.7% above market
7.09 RBLX revenue / share×3054.57x ROIV P/S=$21,662.22
Market $43.31Implied $21,662.22